Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
General Thoracic and Cardiovascular Surgery|October 31, 2014
Current status of induction treatment for N2-Stage III non-small cell lung cancerMasafumi Yamaguchi, Kenji SugioBiochemical and Biophysical Research Communications|October 8, 2023
M phase-specific interaction between SBDS and RNF2 at the mitotic spindles regulates mitotic progressionYukihiro Sera, Tsuneo Imanaka, Masafumi YamaguchiGan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2003
[Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer]Masafumi Yamaguchi, Yasuaki Fukuyama, Yukito IchinoseRespiration; International Review of Thoracic Diseases|September 22, 2011
Erdheim-Chester disease presenting with pneumothoraxMasafumi Yamaguchi, Tetsuhiro Shiota, Yoichiro KobashiAnnals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|May 21, 2011
A complication of thoracic surgery: a late-onset chylomediastinum resulting from a left upper lobectomy and lymph node dissection through a median sternotomyRyuichi Suemitsu, Sadanori Takeo, Masafumi Yamaguchi, et al.Cancer Chemotherapy and Pharmacology|October 8, 2009
Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancerMasafumi Yamaguchi, Sadanori Takeo, Ryuichi Suemitsu, et al.Drug Discoveries & Therapeutics|October 27, 2024
Mitotic abnormalities and spindle assembly checkpoint inactivation in a cell model of Shwachman-Diamond syndrome with mutations in the Shwachman-Bodian-Diamond syndrome gene, 258+2T > CYukihiro Sera, Tsuneo Imanaka, Yusuke Iguchi, et al.Anticancer Research|October 1, 2021
Immunonutritional Indices in Non-small-cell Lung Cancer Patients Receiving Adjuvant Platinum-based ChemotherapyTaichi Matsubara, Fumihiko Hirai, Masafumi Yamaguchi, et al.Clinical Lung Cancer|February 17, 2024
Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE TrialTaichi Matsubara, Masafumi Yamaguchi, Mototsugu Shimokawa, et al.Biochemical and Biophysical Research Communications|November 12, 2021
Development of simultaneous quantitative analysis of tricarboxylic acid cycle metabolites to identify specific metabolites in cancer cells by targeted metabolomic approachTetsushi Yamamoto, Kanta Sato, Masafumi Yamaguchi, et al.Pageof 19